Mandibular Device Comparable to CPAP to Reduce BP Mandibular Device Comparable to CPAP to Reduce BP
A mandibular advancement device was non-inferior to standard of care CPAP to reduce blood pressure in patients with hypertension and sleep apnea in the CRESCENT trial.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 7, 2024 Category: Cardiology Tags: Cardiology Source Type: news
Impella CP Improves Survival in STEMI, Cardiogenic Shock Impella CP Improves Survival in STEMI, Cardiogenic Shock
Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 7, 2024 Category: Cardiology Tags: Cardiology Source Type: news
ApoA1 Trial Misses Endpoint, But HDL Hypothesis Still Alive? ApoA1 Trial Misses Endpoint, But HDL Hypothesis Still Alive?
ApoA1 infusions in acute MI did not significantly reduce the composite endpoint in the AEGIS-II trial. However, an exploratory analysis suggested benefit at higher LDL levels.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 6, 2024 Category: Cardiology Tags: Cardiology Source Type: news
No Net HF Benefit for Interarterial Shunt Device No Net HF Benefit for Interarterial Shunt Device
For an all-comer population with any impairment of LV function, an interarterial shunt device missed the primary endpoint in RELIEVE-HF, but benefit was seen with LVEF less than 40%.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 6, 2024 Category: Cardiology Tags: Cardiology Source Type: news
Apr 05 2024 This Week in Cardiology Apr 05 2024 This Week in Cardiology
Statins and diabetes, AAD in patients with heart disease, tricuspid valve interventions, and an ACC preview are the topics John Mandrola, MD, discusses in this week ’s podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 5, 2024 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Clinicians Slam FDA Over Approval of Opioid Addiction Test Clinicians Slam FDA Over Approval of Opioid Addiction Test
Researchers say a test meant to measure risk for opioid use disorder may cause harm. Their arguments are part of a larger debate about using genetic information to guide clinical care.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 5, 2024 Category: Cardiology Tags: Family Medicine/Primary Care Source Type: news
SGLT2 Inhibitors Safe for HF in Congenital Heart Disease SGLT2 Inhibitors Safe for HF in Congenital Heart Disease
SGLT2 inhibitors not only were safe in adult patients with congenital heart disease who develop heart failure but also were associated with reduced hospitalizations.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 5, 2024 Category: Cardiology Tags: Cardiology Source Type: news
Heart-1 Gene Therapy Trial Pauses Enrollment Heart-1 Gene Therapy Trial Pauses Enrollment
A phase 1 gene editing trial in patients with heterozygous familial hypercholesterolemia and atherosclerotic CVD was paused after abnormal lab results were seen.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 4, 2024 Category: Cardiology Tags: Cardiology Source Type: news
Lp(a) Tied to Higher CVD Events; Risk Reduction With IPE Lp(a) Tied to Higher CVD Events; Risk Reduction With IPE
New analysis of the REDUCE-IT trial suggested benefit of icosapent ethyl doesn ' t vary by Lp(a) level and confirmed risk for Lp(a) with high triglycerides but not cholesterol.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 4, 2024 Category: Cardiology Tags: Cardiology Source Type: news
Mandrola's Three Trials to Look For at the 2024 ACC Mandrola's Three Trials to Look For at the 2024 ACC
Trials on chelation therapy, the Impella device, and beta-blockers are cardiologist John Mandrola ' s picks for the upcoming American College of Cardiology Meeting in Atlanta.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 2, 2024 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Dyslipidemia in Canada: High Prevalence and Treatment Gaps Dyslipidemia in Canada: High Prevalence and Treatment Gaps
Physicians should pay attention to patients with higher risks for not receiving treatment, such as women and patients with normal BMI, said researchers.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 1, 2024 Category: Cardiology Tags: Cardiology Source Type: news
Mar 29 2024 This Week in Cardiology Mar 29 2024 This Week in Cardiology
Intermittent fasting, anticoagulation decisions, heterogenous treatment effects, frailty in HF, the importance of the ECG, and industry conflicts are the topics John Mandrola, MD, covers this week.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 30, 2024 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Reducing Alcohol Intake Tied to Fewer CV Events Reducing Alcohol Intake Tied to Fewer CV Events
The benefits of changing drinking behavior among those with higher intakes were due mainly to significant reductions in angina and ischemic stroke.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 29, 2024 Category: Cardiology Tags: Cardiology Source Type: news
No Increased Stroke Risk After COVID-19 Bivalent Vaccine No Increased Stroke Risk After COVID-19 Bivalent Vaccine
There is no increased risk for stroke during the 6 weeks following receipt of either brand of the COVID-19 bivalent vaccine, new research shows.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 28, 2024 Category: Cardiology Tags: Neurology & Neurosurgery Source Type: news
US FDA Approves Merck's Therapy for Rare Lung Condition US FDA Approves Merck's Therapy for Rare Lung Condition
The U.S. Food and Drug Administration on Tuesday approved Merck ' s treatment for adults with high blood pressure due to constriction of lung arteries, adding another...Reuters Health Information (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 26, 2024 Category: Cardiology Tags: Pulmonary Medicine Source Type: news
